Address
Email address
Phone number
Hambakliinik aadressil Laulupeo 2, Tallinna kesklinn. Broneeri aeg: tel 660 66 64 või tel 50 250 79. Kirjuta meile [email protected]. Kohtumiseni!
Name
OÜ Densprax
Registry code
12051586
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
31.01.2011 (13)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86231 - Provision of dental treatment
917 766 €
105 943 €
12%
1 598 €
(estimate is approximate)
475 739 €
19
Submitted
No tax arrears
22%
18%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Raili Luikmel 05.04.1979 (45) | 100% - 2 500.00 EUR | Board member | Direct ownership | |
Tiina Kurrik 03.07.1979 (45) | - | - | - | Founder |
2019 25.06.2020 | 2020 30.06.2021 | 2021 30.06.2022 | 2022 30.06.2023 | 2023 30.06.2024 | |
---|---|---|---|---|---|
Total Revenue | 381 067 € | 416 251 € | 632 862 € | 820 925 € | 917 766 € |
Net profit (loss) for the period | 56 276 € | 67 005 € | 106 884 € | 142 742 € | 105 943 € |
Profit Margin | 15% | 16% | 17% | 17% | 12% |
Current Assets | 270 567 € | 323 017 € | 426 875 € | 501 984 € | 592 969 € |
Fixed Assets | 1 148 € | 459 € | 7 482 € | 5 394 € | 3 306 € |
Total Assets | 271 715 € | 323 476 € | 434 357 € | 507 378 € | 596 275 € |
Current Liabilities | 45 050 € | 55 306 € | 76 303 € | 94 582 € | 120 536 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 226 665 € | 268 170 € | 358 054 € | 412 796 € | 475 739 € |
Employees | 10 | 12 | 14 | 14 | 19 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | 57 856.43 € | 59 979.65 € | 22 |
2023 Q4 | - | 45 010.67 € | 47 923.8 € | 21 |
2023 Q3 | - | 59 122.5 € | 55 652.42 € | 19 |
2023 Q2 | - | 39 071.64 € | 41 509.71 € | 19 |
2023 Q1 | - | 40 822.49 € | 43 247.02 € | 19 |
2022 Q4 | - | 32 086.43 € | 34 073.44 € | 15 |
2022 Q3 | - | 40 541.83 € | 34 103.02 € | 15 |
2022 Q2 | - | 27 668.4 € | 29 326.6 € | 13 |
2022 Q1 | - | 41 709.31 € | 31 544.69 € | 14 |
2021 Q4 | - | 28 146.67 € | 27 068.83 € | 14 |
2021 Q3 | - | 27 104.03 € | 28 415.55 € | 14 |
2021 Q2 | - | 20 636.76 € | 22 270.91 € | 15 |
2021 Q1 | - | 19 637.29 € | 21 237.78 € | 14 |
2020 Q4 | - | 21 558.97 € | 17 951.76 € | 15 |
2020 Q3 | - | 17 919.41 € | 18 324.43 € | 13 |
2020 Q2 | - | 11 221.29 € | 12 204.08 € | 13 |
2020 Q1 | - | 14 508.67 € | 15 634.92 € | 12 |